Treatment efficacy | SD (≤55 Gy) | HD-conventional (55–63 Gy) | HD-ultra (≥ 63 Gy) | χ² | P |
---|---|---|---|---|---|
Cervical ESCA | Â | Â | Â | 6.635 | 0.036 |
ORR | 50% (12) a* | 68.7% (103) a, b* | 79.6% (39)b* | Â | Â |
Non-ORR | 50% (12) a* | 31.3% (47) a, b* | 20.4% (10)b* | Â | Â |
Upper thoracic ESCA | Â | Â | Â | 8.204 | 0.017 |
ORR | 57.0% (61)a* | 64.8% (302) a, b* | 74.4% (99)b* | Â | Â |
Non-ORR | 43.0% (46)a* | 35.2% (164) a, b* | 25.6% (34)b* | Â | Â |